UA97619C2 - Гидрогалогенидный комплекс агомелатина и способ его получения - Google Patents
Гидрогалогенидный комплекс агомелатина и способ его полученияInfo
- Publication number
- UA97619C2 UA97619C2 UAA201111232A UAA201111232A UA97619C2 UA 97619 C2 UA97619 C2 UA 97619C2 UA A201111232 A UAA201111232 A UA A201111232A UA A201111232 A UAA201111232 A UA A201111232A UA 97619 C2 UA97619 C2 UA 97619C2
- Authority
- UA
- Ukraine
- Prior art keywords
- preparation
- agomelatine
- hydrohalide complex
- complex
- product
- Prior art date
Links
- YJYPHIXNFHFHND-UHFFFAOYSA-N agomelatine Chemical compound C1=CC=C(CCNC(C)=O)C2=CC(OC)=CC=C21 YJYPHIXNFHFHND-UHFFFAOYSA-N 0.000 title abstract 4
- 229960002629 agomelatine Drugs 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 4
- 238000010668 complexation reaction Methods 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B7/00—Halogens; Halogen acids
- C01B7/01—Chlorine; Hydrogen chloride
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B7/00—Halogens; Halogen acids
- C01B7/09—Bromine; Hydrogen bromide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Данное изобретение касается гидрогалогенидного комплекса агомелатина и способа его получения. Гидрогалогенидный комплекс агомелатина, полученный с помощью данного способа, является более растворимым, более стабильным и имеет лучшую степень чистоты, чем агомелатин сам по себе, что делает его более пригодным для применения в фармацевтических препаратах. Используя раскрытый способ, продукт с лучшей степенью чистоты могут получать с помощью неосложненного способа без привлечения дополнительных трудных этапов.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100467821A CN101481321B (zh) | 2009-02-27 | 2009-02-27 | 阿戈美拉汀卤化氢复合物及其制备方法 |
| PCT/CN2010/070780 WO2010097052A1 (zh) | 2009-02-27 | 2010-02-26 | 阿戈美拉汀卤化氢复合物及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA97619C2 true UA97619C2 (ru) | 2012-02-27 |
Family
ID=40878634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201111232A UA97619C2 (ru) | 2009-02-27 | 2010-02-26 | Гидрогалогенидный комплекс агомелатина и способ его получения |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US8524949B2 (ru) |
| EP (1) | EP2418195B1 (ru) |
| JP (1) | JP5426693B2 (ru) |
| KR (1) | KR101284202B1 (ru) |
| CN (1) | CN101481321B (ru) |
| AP (1) | AP3048A (ru) |
| AU (1) | AU2010217082B2 (ru) |
| BR (1) | BRPI1008767B1 (ru) |
| CA (1) | CA2753449C (ru) |
| CL (1) | CL2011002090A1 (ru) |
| CO (1) | CO6420335A2 (ru) |
| CR (1) | CR20110446A (ru) |
| CU (1) | CU20110163A7 (ru) |
| CY (1) | CY1117100T1 (ru) |
| DK (1) | DK2418195T3 (ru) |
| EA (1) | EA021939B1 (ru) |
| EC (1) | ECSP11011290A (ru) |
| ES (1) | ES2530730T3 (ru) |
| GE (1) | GEP20156221B (ru) |
| HN (1) | HN2011002291A (ru) |
| HR (1) | HRP20150072T1 (ru) |
| IL (1) | IL214682A (ru) |
| MA (1) | MA33063B1 (ru) |
| MX (1) | MX2011008946A (ru) |
| MY (1) | MY154015A (ru) |
| NI (1) | NI201100163A (ru) |
| NZ (1) | NZ594773A (ru) |
| PE (1) | PE20120652A1 (ru) |
| PL (1) | PL2418195T3 (ru) |
| PT (1) | PT2418195E (ru) |
| RS (1) | RS53751B1 (ru) |
| SG (1) | SG173691A1 (ru) |
| SI (1) | SI2418195T1 (ru) |
| UA (1) | UA97619C2 (ru) |
| WO (1) | WO2010097052A1 (ru) |
| ZA (1) | ZA201106048B (ru) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102106806B (zh) * | 2009-12-29 | 2013-04-17 | 上海中西制药有限公司 | 一种固体制剂的制备方法及所得固体制剂 |
| CN102190595A (zh) * | 2010-03-17 | 2011-09-21 | 上海医药工业研究院 | 阿戈美拉汀溴化氢水合物及其制备方法 |
| CN102190594A (zh) | 2010-03-17 | 2011-09-21 | 上海医药工业研究院 | 阿戈美拉汀氯化氢水合物及其制备方法 |
| CN101870662B (zh) * | 2010-05-21 | 2013-03-20 | 中山大学 | 结晶型阿戈美拉汀溶剂化物及其制备方法 |
| WO2012046253A2 (en) * | 2010-10-08 | 2012-04-12 | Msn Laboratories Limited | Process for the preparation of n-[2- (7-methoxy-l-naphthyl) ethyl] acetamide and its novel crystalline forms |
| PL2517700T3 (pl) * | 2011-04-28 | 2013-12-31 | Zentiva Ks | Farmaceutyczne dopuszczalne kokryształy n-[2-(7-metoksy-1-naftylo]acetamidu i sposoby ich wytwarzania |
| EP2551257A1 (en) * | 2011-07-28 | 2013-01-30 | Laboratorios Del. Dr. Esteve, S.A. | Co-crystals of agomelatine with co-crystal-formers |
| FR2978916B1 (fr) | 2011-08-10 | 2013-07-26 | Servier Lab | Composition pharmaceutique solide pour administration buccale d'agomelatine |
| CN102702008B (zh) * | 2012-06-03 | 2014-05-28 | 上海右手医药科技开发有限公司 | 阿戈美拉汀硫酸复合物及其制备方法 |
| CN102702041B (zh) * | 2012-05-14 | 2013-08-14 | 上海右手医药科技开发有限公司 | 阿戈美拉汀苯磺酸类复合物及其制备方法 |
| EP2851363B1 (en) * | 2012-05-14 | 2018-01-03 | Shanghai Righthand Pharmtech. Co., Ltd. | Agomelatine acid radical composite, and preparation method and application thereof |
| CN102718675B (zh) * | 2012-06-07 | 2015-03-25 | 上海右手医药科技开发有限公司 | 阿戈美拉汀甲磺酸复合物及其制备方法 |
| ES2590908T3 (es) * | 2012-12-17 | 2016-11-24 | Dr. Reddy's Laboratories Ltd. | Cocristal de agomelatina con ácido fosfórico |
| WO2014096373A1 (en) | 2012-12-21 | 2014-06-26 | Laboratorios Lesvi, S. L. | Process for prepararing n-(2-(7-methoxy-1-naphthalenyl)ethyl) acetamide and solid forms thereof |
| FR3001894A1 (fr) | 2013-02-08 | 2014-08-15 | Servier Lab | Composition pharmaceutique solide pour administration buccale d'agomelatine |
| EA031237B1 (ru) * | 2013-07-29 | 2018-12-28 | Ле Лаборатуар Сервье | Новые комплексы агомелатина и сульфокислот, способ их получения и фармацевтические композиции, которые их содержат |
| MX369301B (es) * | 2013-07-31 | 2019-11-05 | Servier Lab | Nuevas formas de co-cristales de agomelatina y de acido p-toluenosulfonico, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2658818B1 (fr) * | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| FR2778662B1 (fr) * | 1998-05-12 | 2000-06-16 | Adir | Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2795326B1 (fr) * | 1999-06-28 | 2001-08-31 | Adir | Composition pharmaceutique solide thermoformable a liberation controlee |
| JP4522851B2 (ja) | 2002-05-24 | 2010-08-11 | バイエル・クロツプサイエンス・アクチエンゲゼルシヤフト | チオアルキルアミン誘導体の調製方法 |
| WO2005068413A1 (ja) * | 2004-01-15 | 2005-07-28 | Tosoh Corporation | フルオレン基を母核とするアミン化合物、該アミン化合物の製造方法及び該アミン化合物の用途 |
| FR2866335B1 (fr) | 2004-02-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese de l'agomelatine |
| FR2889523B1 (fr) * | 2005-08-03 | 2007-12-28 | Servier Lab | Nouvelle forme cristalline v de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
| FR2899472B1 (fr) * | 2006-04-07 | 2008-09-12 | Servier Lab | Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble anxiete generalisee |
-
2009
- 2009-02-27 CN CN2009100467821A patent/CN101481321B/zh not_active Expired - Fee Related
-
2010
- 2010-02-26 BR BRPI1008767-2A patent/BRPI1008767B1/pt not_active IP Right Cessation
- 2010-02-26 NZ NZ594773A patent/NZ594773A/xx not_active IP Right Cessation
- 2010-02-26 UA UAA201111232A patent/UA97619C2/ru unknown
- 2010-02-26 PT PT107458366T patent/PT2418195E/pt unknown
- 2010-02-26 JP JP2011551399A patent/JP5426693B2/ja not_active Expired - Fee Related
- 2010-02-26 MY MYPI2011003884A patent/MY154015A/en unknown
- 2010-02-26 GE GEAP201012388A patent/GEP20156221B/en unknown
- 2010-02-26 DK DK10745836T patent/DK2418195T3/en active
- 2010-02-26 RS RS20150040A patent/RS53751B1/sr unknown
- 2010-02-26 WO PCT/CN2010/070780 patent/WO2010097052A1/zh not_active Ceased
- 2010-02-26 KR KR1020117021812A patent/KR101284202B1/ko not_active Expired - Fee Related
- 2010-02-26 PE PE2011001512A patent/PE20120652A1/es not_active Application Discontinuation
- 2010-02-26 MA MA34120A patent/MA33063B1/fr unknown
- 2010-02-26 CA CA2753449A patent/CA2753449C/en active Active
- 2010-02-26 MX MX2011008946A patent/MX2011008946A/es active IP Right Grant
- 2010-02-26 EP EP10745836.6A patent/EP2418195B1/en active Active
- 2010-02-26 SI SI201030872T patent/SI2418195T1/sl unknown
- 2010-02-26 HR HRP20150072AT patent/HRP20150072T1/hr unknown
- 2010-02-26 AU AU2010217082A patent/AU2010217082B2/en not_active Ceased
- 2010-02-26 ES ES10745836T patent/ES2530730T3/es active Active
- 2010-02-26 US US13/138,511 patent/US8524949B2/en not_active Expired - Fee Related
- 2010-02-26 SG SG2011058542A patent/SG173691A1/en unknown
- 2010-02-26 EA EA201101208A patent/EA021939B1/ru unknown
- 2010-02-26 PL PL10745836T patent/PL2418195T3/pl unknown
- 2010-02-26 AP AP2011005845A patent/AP3048A/xx active
-
2011
- 2011-08-16 IL IL214682A patent/IL214682A/en active IP Right Grant
- 2011-08-17 ZA ZA2011/06048A patent/ZA201106048B/en unknown
- 2011-08-19 CR CR20110446A patent/CR20110446A/es unknown
- 2011-08-23 CU CU20110163A patent/CU20110163A7/es unknown
- 2011-08-26 HN HN2011002291A patent/HN2011002291A/es unknown
- 2011-08-26 CO CO11109274A patent/CO6420335A2/es not_active Application Discontinuation
- 2011-08-26 NI NI201100163A patent/NI201100163A/es unknown
- 2011-08-26 CL CL2011002090A patent/CL2011002090A1/es unknown
- 2011-08-26 EC EC2011011290A patent/ECSP11011290A/es unknown
-
2015
- 2015-01-22 CY CY20151100070T patent/CY1117100T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA97619C2 (ru) | Гидрогалогенидный комплекс агомелатина и способ его получения | |
| MY160460A (en) | Agomelatine hydrochloride hydrate and preparation thereof | |
| MY182428A (en) | Crystalline forms of a prolyl hydroxylase inhibitor | |
| MX2020012596A (es) | Procesos e intermedios para preparar un medicamento. | |
| WO2015145415A3 (en) | Ibrutinib solid forms and production process therefor | |
| PH12012501757A1 (en) | Agomelatine hydrochloride hydrate and preparation thereof | |
| MY172601A (en) | Improved process for preparing fermented soybean meal | |
| EP4417605A3 (en) | Method for synthesis of eliglustat and intermediate compounds thereof | |
| MY160625A (en) | Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation | |
| AU2016237099B2 (en) | Method for producing novel nitrogen-containing compound or salt thereof, and production intermediate of same | |
| MX343612B (es) | Proceso para la preparacion de metoximelonal. | |
| TN2012000436A1 (en) | Agomelatine hydrobromide hydrate and preparation thereof | |
| IN2014KN02722A (ru) | ||
| EP2609815A4 (en) | PROCESS FOR PRODUCTION OF FISH PASTE PRODUCT, AND ENZYMA PREPARATION FOR MODIFICATION OF FISH PASTE PRODUCT | |
| HRP20210966T1 (hr) | Sinteza trans-8-kloro-5-metil-1-[4-(piridin-2-iloksi)-cikloheksil]-5,6-dihidro-4h-2,3,5,10b-tetraazabenzo[e]azulena i njegovih kristalnih oblika | |
| WO2012115402A3 (en) | Crystalline form of docetaxel and process for preparation thereof | |
| MX2012001722A (es) | Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable. | |
| MY165659A (en) | Novel method of preparing benzoimidazole derivatives | |
| TN2011000425A1 (en) | Agomelatine hydrohalide complex and preparation method thereof | |
| WO2011152657A3 (en) | Acetyl-l-carnitine malate, process for preparing the same, and pharmaceutical composition comprising the same | |
| MD4477B1 (ru) | Способ синтеза 3-(2-бромо-4,5-диметоксифенил)пропаннитрила и его применение в синтезе ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой | |
| WO2019088800A3 (ko) | 폴리에틸렌글리콜 유도체 및 이의 제조방법 | |
| MX2013002990A (es) | Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable. | |
| PH12015502000B1 (en) | Processes and intermediates for preparing a medicament | |
| TN2015000162A1 (en) | Process for preparing meropenem trihydrate |